Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04722822 · ClinicalTrials.gov registry record · NA
The HPV 9-10 Trial: Early Initiation of HPV Vaccination
A NA study of Hpv, sponsored by University of Colorado, Denver.
- Recruiting
- Registry status
- NA
- Development phase
- 3,100
- Enrollment target
- 2
- Study locations
NCT04722822 is a NA study of Hpv that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 3,100 participants, above the 2,112-participant average among 24 other Hpv trials with a reported enrollment target (47% higher). The trial reports 2 study locations across 2 states.
The verdict
NCT04722822, a NA study of Hpv, is actively recruiting participants, sponsored by University of Colorado, Denver.
- RECRUITING
- Registry status
- NA
- Development phase
- 3,100 participants
- Enrollment target
- 2
- Study locations
Study Summary
Every year, thousands of Americans die from cancers related to human papillomavirus (HPV). The vast majority of those deaths could be prevented with a safe and effective vaccine, yet many parents choose not have their children vaccinated when it is recommended at age 11 or 12. In this study, we will examine in a randomized trial whether earlier initiation of the vaccine at age 9-10 years will result in less parental refusal and higher rates of full vaccination at younger ages, before early sexual activity begins.
Conditions Studied
Interventions
- BEHAVIORAL (Intervention) Recommending HPV vaccine for patients 9-10 years of age
- BEHAVIORAL (Control) Recommending HPV vaccine for patients 11-12 years of age
Study Locations (2)
California
- University of California at Los Angeles - Los Angeles
Colorado
- University of Colorado - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,100 participants |
| Start Date | 2019-12-23 |
| Est. Completion | 2027-04-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04722822
The ClinicalTrials.gov registry entry for NCT04722822 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 3,100 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 2,112-participant average among 24 other Hpv trials with a reported enrollment target (47% higher). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hpv appearing as the primary indexed condition, and to 2 interventions - of which (Intervention) Recommending HPV vaccine for patients 9-10 years of age is the first listed.
NCT04722822 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Colorado.
Frequently Asked Questions
What is clinical trial NCT04722822 about?
NCT04722822 is a clinical study titled "The HPV 9-10 Trial: Early Initiation of HPV Vaccination". Every year, thousands of Americans die from cancers related to human papillomavirus (HPV). The vast majority of those deaths could be prevented with a safe and effective vaccine, yet many parents choose not have their children vaccinated when it is recommended at age 11 or 12. In this study, we will...
What is the current status of trial NCT04722822?
This trial is currently recruiting. It is a NA study. The enrollment target is 3,100 participants. The study started on 2019-12-23. Estimated completion is 2027-04-01.
What conditions does trial NCT04722822 study?
This clinical trial studies the following conditions: Hpv.
What interventions are being tested in trial NCT04722822?
The interventions under investigation include: (Intervention) Recommending HPV vaccine for patients 9-10 years of age (BEHAVIORAL), (Control) Recommending HPV vaccine for patients 11-12 years of age (BEHAVIORAL).
Who is sponsoring clinical trial NCT04722822?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04722822 being conducted?
This trial has 2 study locations across California, Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hpv
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
PopSci CHW4CervixHealth
RECRUITING · NA
-
Stand Up 2 HPV: Standing Orders to Improve HPV Vaccination
RECRUITING · NA
-
HPV Self-Collection Program
RECRUITING · NA
-
Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer
RECRUITING · NA
-
Prevención en Sus Manos: Feasibility of a Novel Community-Based Strategy to Improve Access to Cervical Cancer Screening
RECRUITING · NA
-
Playing Game to Learn About Children's Vaccine Project
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.